DAYURI GALLARDO: Open Payments
NPI 1417414046 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$427 in 17 payments from 7 companies in 2025. Trend: 2023 $24 · 2024 $438 · 2025 $427
Food & beverage: $427
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $194 |
| Novo Nordisk Inc | 6 | $110 |
| AstraZeneca Pharmaceuticals LP | 2 | $55 |
| Exact Sciences Corporation | 1 | $19 |
| Dexcom, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: Ozempic, MOUNJARO, Wegovy, JARDIANCE, The Cologuard Plus Collection Kit, Dexcom G6 Transmitter, OTEZLA, Rybelsus.
Industry payments across FL — which companies pay providers there.
